Beranda › Kanker (semua jenis) › North Carolina › Durham
Uji klinis Kanker (semua jenis) di Durham, NC
58 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Durham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Menerima pesertaFase 1/2
- GSK Investigational Site, Durham
A Study of PHN-012 in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- PHN-012-001 Site, Durham
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Menerima pesertaStudi observasional
- The University of North Carolina Chapel Hill, Chapel Hill · 10 mi jauhnya
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Menerima pesertaFase 2/3
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
- University of North Carolina Hospitals at Hillsborough, Hillsborough · 13 mi jauhnya
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Menerima pesertaFase 3
- Duke University Medical Center, Durham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Menerima pesertaFase 3
- Duke University Medical Center - Duke Cancer Centre, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Menerima pesertaFase 3
- Quetzal Site 27, Chapel Hill · 10 mi jauhnya
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi jauhnya
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Menerima pesertaFase 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Menerima pesertaFase 2/3
- Duke University Medical Center, Durham
- The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Digital Art Therapy for Young Cancer Survivors
Menerima peserta
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
Menerima pesertaFase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill · 10 mi jauhnya
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Menerima pesertaFase 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Menerima pesertaFase 1/2
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill · 10 mi jauhnya
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Menerima pesertaFase 1
- Duke Cancer Institute, Durham
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- Duke Cancer Institute, Durham
- University of North Carolina Medical Center, Chapel Hill · 10 mi jauhnya
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Menerima pesertaFase 3
- Duke Cancer Center, Durham
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
Menerima peserta
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Menerima pesertaFase 3
- University of North Carolina Chapel Hill, Chapel Hill · 10 mi jauhnya
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Menerima pesertaFase 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Duke University, Durham
Behavioral Pain Intervention for Older Cancer Patients
Menerima peserta
- Duke Cancer Network, Durham
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Menerima pesertaFase 1
- Duke Cancer Institute, Durham
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
Menerima pesertaSukarelawan sehat diterima
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Menerima pesertaFase 1/2
- University of North Carolina at Chapel Hill /ID# 274667, Chapel Hill · 10 mi jauhnya
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1
- University of North Carolina /ID# 251203, Chapel Hill · 10 mi jauhnya
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Menerima pesertaFase 2
- Duke University Medical Center /ID# 279457, Durham
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Menerima pesertaFase 1
- Duke Cancer Center, Durham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Menerima peserta
- University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Menerima pesertaSukarelawan sehat diterima
- University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill · 10 mi jauhnya
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Menerima peserta
- Durham VA Medical Center, Durham, NC, Durham
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Menerima pesertaStudi observasional
- University of North Carolina, Chapel Hill · 10 mi jauhnya
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Menerima pesertaFase 1
- Research Site, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Menerima pesertaFase 1
- Duke Cancer Center /ID# 251975, Durham
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Menerima pesertaFase 2
- Duke Comprehensive Cancer Center, Durham
- University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
Menerima peserta
- Durham VA Medical Center, Durham, NC, Durham
Improving Outcomes in Early Menopause After Cancer
Menerima peserta
- Duke Cancer Institute, Durham
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
Menerima pesertaStudi observasional
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
Pilot Study of Mindset Moments Among Adolescent and Young Adult Cancer Survivors
Menerima pesertaSukarelawan sehat diterima
- Duke Cancer Institute, Durham
UNC Metastatic Cancer Radiation Therapy Registry
Menerima pesertaStudi observasional
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill · 10 mi jauhnya
Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine Tumors
Menerima pesertaStudi observasional
- UNC Hospitals, Chapel Hill · 10 mi jauhnya
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Menerima pesertaFase 1/2
- Duke University Medical Center, Duke Cancer Center, Durham
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Menerima peserta
- Durham VA Medical Center, Durham, NC, Durham
Rehabilitation Outcomes Study
Menerima peserta
- The N.C. Cancer Hospital, Chapel Hill · 10 mi jauhnya
Cancer and Mild Cognitive Impairment Dyadic Intervention
Menerima peserta
- Duke University, Durham
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Menerima pesertaFase 2
- University of North Carolina /ID# 233313, Chapel Hill · 10 mi jauhnya
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- Duke University, Durham
- UNC, Chapel Hill · 10 mi jauhnya
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
Menerima peserta
- Duke Cancer Institute, Durham
Effectiveness of Central Oncology Navigation and the Use of an ORN
Menerima peserta
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
Menerima peserta
- Duke University School of Medicine, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi jauhnya
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Menerima pesertaStudi observasional
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauhnya
Young Adult Infusion Space Experience Satisfaction Survey
Menerima pesertaStudi observasional
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
UNC Pleural Fluid Registry
Menerima pesertaStudi observasional
- UNC Lingeberger Comprehensive Cancer Center, Chapel Hill · 10 mi jauhnya
A Study of NX-1607 in Adults With Advanced Malignancies
Menerima pesertaFase 1
- University of North Carolina, Chapel Hill · 10 mi jauhnya
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Menerima peserta
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi jauhnya
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · 13 mi jauhnya
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY109 studi
- Boston, MA85 studi
- Los Angeles, CA74 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Atlanta, GA49 studi
- Seattle, WA49 studi
- Arlington, VA48 studi
- St. Louis, MO46 studi
Studi lain di Durham
- Kanker Payudara64 studi
- Kanker Paru Non-Sel Kecil39 studi
- Mieloma Multipel37 studi
- Leukemia Mieloid Akut33 studi
- Kanker Metastatik33 studi
- Kanker Prostat32 studi
- Kanker Paru32 studi
- Kanker Kolorektal28 studi
- Kanker Ovarium27 studi
- Leukemia Limfositik Kronis27 studi
- Gagal Jantung26 studi
- Kanker Pankreas24 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.